Effects of Whole Body Vibration on Quadriceps Function, Landing Biomechanics, and Performance in Individuals With ACL Reconstruction
25 juin 2026 mis à jour par: University of North Carolina, Chapel Hill
Use of Whole-body Vibration to Acutely Improve Landing Biomechanics In Individuals With Anterior Cruciate Ligament Reconstruction (ACLR)
Individuals who undergo anterior cruciate ligament reconstruction (ACLR) are at heightened risk of secondary anterior cruciate ligament (ACL) injury (e.g.
additional injury to the ACL in either knee).
One of the primary physiological consequences of ACLR is the presence of quadriceps dysfunction (i.e.
reduced activation and strength) which has been linked to altered gait and landing biomechanics.
Aberrant landing biomechanics have been associated with an increased risk of both primary and secondary ACL injury, thus additional research is needed to evaluate the efficacy of treatments aimed to reduce quadriceps dysfunction and restore adequate landing biomechanics in attempts to reduce secondary ACL injury.
Whole-body Vibration (WBV) has demonstrated success in improving quadriceps function and gait biomechanics in individuals with ACLR, however its effectiveness on landing biomechanics is unknown.
To evaluate the acute effects of WBV on landing biomechanics in those with ACLR, a non-randomized crossover-controlled trial was conducted to determine if a single bout of WBV improved landing biomechanics greater than a control condition.
Participants completed two separate testing sessions (separated by at least one week) in which measures of quadriceps function and landing biomechanics were assessed before and after either a control (no WBV) or WBV intervention.
Separate linear mixed-effects models of post-test values for each dependent outcome were conducted with condition (control vs WBV) and limb (ACLR vs Uninvolved) as an interaction term, and each condition pre-test values and time post-ACLR as fixed effect covariates and a random effect of subject.
The investigators expect to observe a significant improvement in landing biomechanics following WBV compared to the control condition.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Réel)
36
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
North Carolina
-
Chapel Hill, North Carolina, États-Unis, 27599
- Univesrity of North Carolina at Chapel HIll MOTION Science Institute
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Between the ages of 18-35
- History of primary, unilateral ACLR
- Medically cleared for unrestricted physical activity
Exclusion Criteria:
- More than 5 years removed from ACLR
- Currently pregnant
- History of other lower extremity surgery
- History of lower extremity injury in previous 6 months
- History of neurological disorder
- Maximal isometric quadriceps torque > 3.0 Nm/kg in the ACLR limb
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Non randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Whole body vibration followed by No Intervention (Control)
Participants in this arm will receive Whole Body Vibration followed by a washout period of 1 week, then receive the Sham Whole body vibration (Control).
Each condition will be evaluated in a single session (i.e.
acute effects).
|
Participants will stand on a WBV platform in a mini-squat position while vibration is applied during six 60-second bouts with 2 minutes of rest between each bout.
WBV will be delivered at an acceleration of 2g and a frequency of 30 Hz.
Participants will stand on a WBV platform in a mini-squat position during six 60-second bouts with 2 minutes of rest between each bout.
No vibration will be applied.
|
|
Expérimental: Sham Whole body vibration (Control) followed by Whole Body Vibration
Participants in this arm will receive Sham Whole body vibration (Control) followed by a washout period of 1 week, then receive Whole Body Vibration.
Each condition will be evaluated in a single session (i.e.
acute effects).
|
Participants will stand on a WBV platform in a mini-squat position while vibration is applied during six 60-second bouts with 2 minutes of rest between each bout.
WBV will be delivered at an acceleration of 2g and a frequency of 30 Hz.
Participants will stand on a WBV platform in a mini-squat position during six 60-second bouts with 2 minutes of rest between each bout.
No vibration will be applied.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Internal Knee Adduction Moment (KAM)
Délai: Separate values prior to and immediately following the intervention (within 5 minutes).
|
Peak value during landing in both single-leg and double-leg tasks averaged over 3 trials and normalized to the product of body weight and height
|
Separate values prior to and immediately following the intervention (within 5 minutes).
|
|
Internal Knee Extension Moment (KEM)
Délai: Separate values prior to and immediately following the intervention (within 5 minutes).
|
Peak value during landing in both single-leg and double-leg tasks averaged over 3 trials and normalized to a product of body weight*height
|
Separate values prior to and immediately following the intervention (within 5 minutes).
|
|
Knee Flexion Angle (KFA)
Délai: Separate values prior to and immediately following the intervention (within 5 minutes).
|
Peak value during landing in both single-leg and double-leg tasks averaged over 3 trials
|
Separate values prior to and immediately following the intervention (within 5 minutes).
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Dynamic Postural Control
Délai: Separate values prior to and immediately following the intervention (within 5 minutes).
|
Time-to-stabilization during single-leg landing
|
Separate values prior to and immediately following the intervention (within 5 minutes).
|
|
Vertical Ground Reaction Force
Délai: Separate values prior to and immediately following the intervention (within 5 minutes).
|
Peak value during landing in both single-leg and double-leg tasks
|
Separate values prior to and immediately following the intervention (within 5 minutes).
|
|
Frontal Plane Kinematics
Délai: Separate values prior to and immediately following the intervention (within 5 minutes).
|
Peak value during landing in both single-leg and double-leg tasks
|
Separate values prior to and immediately following the intervention (within 5 minutes).
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Les enquêteurs
- Chercheur principal: Derek Dewig, University of North Carolina, Chapel Hill
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 septembre 2021
Achèvement primaire (Réel)
22 avril 2022
Achèvement de l'étude (Réel)
10 mai 2022
Dates d'inscription aux études
Première soumission
10 juin 2026
Première soumission répondant aux critères de contrôle qualité
25 juin 2026
Première publication (Réel)
2 juillet 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
2 juillet 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
25 juin 2026
Dernière vérification
1 juin 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 21-0305
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
OUI
Description du régime IPD
Deidentified individual data that supports the results will be shared beginning 9 and continuing for 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.
Délai de partage IPD
IPD will be available beginning 9 and continuing for 36 months following publication.
Critères d'accès au partage IPD
Investigator has approved IRB, IEC, or REB and an executed data use/sharing agreement with UNC.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .